Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Hosted on MSN
10m
Hiroyuki Okuzawa succeeds Sunao Manabe as Daiichi Sankyo CEO
Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed Sunao Manabe as its CEO from 1 April 2025. The company's ...
40m
Roche Receives FDA Approval For The First Companion Diagnostic To Identify Patients With HER2-Ultralow Metastatic Breast Cancer Eligible For ENHERTU
As seen in the DESTINY-Breast06 trial, a pproximately 20-25 percent of hormone receptor (HR)-positive, HER2- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Black boxes recovered
Los Angeles wildfire updates
Cause of death revealed
Cancerous tumor removed
Apologizes for old tweets
Activists call for boycott
Granted legal personhood
Top leaders asked to resign
Asteroid may hit Earth
Recuses self from Act 10 suit
2 more victims in indictment
Searching for joyriders
Sexual misconduct accusation
Confirmed interior secretary
US inflation ticked higher
Ex-worker admits to theft
Hamas confirms death
American hostage to be freed
To raise hourly pay
'As Tears Go By' singer dies
Partners w/ US national labs
Shiffrin finishes 10th
Ground stop amid IT outage
Michigan priest loses license
FDA approves painkiller
Olympic gold medalist dies
Deputy shooting sentence
DOJ sues to block deal
Inmate's transfer blocked
S3 release date revealed
Related topics
Enhertu
AstraZeneca
United States
Food and Drug Administration
Hiroyuki Okuzawa
Feedback